Contrasting the clinical and biological characteristics of young and old COPD patients
Young COPD patients suffer from significant disease burden, display an altered biomarker and disease progression profile reflected by an accelerated risk of lung function decline highlighting the need for early life diagnosis, prevention approaches and treatment.
Authors
- Bartolomé R. Celli (ORCID: https://orcid.org/0000-0002-7266-8371)
- Oriol Sibila (ORCID: https://orcid.org/0000-0002-4833-6713)
- Edwin K. Silverman (ORCID: https://orcid.org/0000-0002-3641-3822)
- Ruth Tal‐Singer (ORCID: https://orcid.org/0000-0002-5275-8062)
- William MacNee (ORCID: https://orcid.org/0000-0002-3692-1448)
- Per Bakke
- Alvar G.N. Agustí (ORCID: https://orcid.org/0000-0003-3271-3788)
- Rosa Faner (ORCID: https://orcid.org/0000-0002-8159-0115)
- Borja G. Cosío (ORCID: https://orcid.org/0000-0002-6388-8209)
- Jørgen Vestbo (ORCID: https://orcid.org/0000-0001-6355-6362)
- Marc Vila
- Joan R. Badia (ORCID: https://orcid.org/0000-0002-1596-0819)
Institutions
- Universitat de Vic - Universitat Central de Catalunya (ES)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Gentofte Hospital (DK)
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Hospital Clínic de Barcelona (ES)
- Health Research Institute of the Balearic Islands (ES)
- Hospital Universitario Son Espases (ES)
- Fundació Clínic per a la Recerca Biomèdica (ES)
- Institute of Infection and Immunity (CA)
- University of Bergen (NO)
- Universitat de Barcelona (ES)
- University of Edinburgh (GB)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1183/23120541.00671-2024
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- GlaxoSmithKline
- Instituto de Salud Carlos III